Publisher Correction: Pricing for Multi-Indication Drugs in the Italian Regulatory Context

Maria Grazia Ursino, Annalisa Milano (), Filippo Viti Angelis, Eva Alessi and Francesco Trotta
Additional contact information
Maria Grazia Ursino: Italian Medicines Agency (AIFA)
Annalisa Milano: Italian Medicines Agency (AIFA)
Filippo Viti Angelis: Italian Medicines Agency (AIFA)
Eva Alessi: Italian Medicines Agency (AIFA)
Francesco Trotta: Italian Medicines Agency (AIFA)

PharmacoEconomics - Open, 2025, vol. 9, issue 3, No 14, 499-499

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-025-00566-2 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:9:y:2025:i:3:d:10.1007_s41669-025-00566-2

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-025-00566-2

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().